The novel HLA‐B *14:118 allele characterized by two different sequencing‐based typing techniques
HLA · 2023
DOI: 10.1111/tan.15096 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2023. Verfasst von Alexandra Jacques und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France. Hauptthemen laut MEDLINE: HLA-B Antigens, Genes, MHC Class I. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
HLA‐B*14:118 differs from HLA‐B*14:93 by two non‐synonymous and one synonymous nucleotide substitution in exon 2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France.
- IMoPa 6, UMR7365 CNRS, Université de Lorraine, Vandoeuvre-les-Nancy, France.
ORCID-Profile: Adèle Dhuyser
Zitieren
APA
Jacques, A., Dhuyser, A., Kennel, A., Clément, S., & Aarnink, A. (2023). The novel HLA‐B *14:118 allele characterized by two different sequencing‐based typing techniques. HLA. https://doi.org/10.1111/tan.15096
Vancouver
Jacques A, Dhuyser A, Kennel A, Clément S, Aarnink A. The novel HLA‐B *14:118 allele characterized by two different sequencing‐based typing techniques. HLA. 2023. doi:10.1111/tan.15096
BibTeX
@article{Jacques2023,
author = {Jacques, Alexandra and Dhuyser, Adèle and Kennel, Anne and Clément, Sandra and Aarnink, Alice},
title = {The novel HLA‐B *14:118 allele characterized by two different sequencing‐based typing techniques},
journal = {HLA},
year = {2023},
doi = {10.1111/tan.15096}
}
EUVIMED